View or Download Statement PDF Contact: Adam Croglia acroglia@trysailstrategies.com FOR IMMEDIATE RELEASE RWC-340B Responds to Senate Bipartisan Request for Information on 340B WASHINGTON, DC – On July…
View or Download PDF July 19, 2023 FOR IMMEDIATE RELEASE Contact: Peggy.Tighe@PowersLaw.com Ryan White Clinic Association Strongly Supports New Legislation Led by U.S. Senators Scott, Lujan, and Peters that…
Click Here to View Key topics to be covered include: 1. Understanding the different ways in which the 340B and Medicaid programs intersect 2. Analyzing CMS’s recently-proposed Medicaid drug…
View PDF Here July 7, 2023 Chair McMorris Rodgers and Ranking Member Crapo: On behalf Ryan White Clinics for 340B Access (RWC-340B), we write in response to your inquiry…
Boehringer Ingelheim (BI) is among the 23 manufacturers that currently restrict contract pharmacy relationships with covered entities. It is also the 16th manufacturer to broaden its restrictions on contract pharmacies following the…
View Here: Pharmaceutical Manufacturer 340B Price Restriction Policies and Exemptions Summary 6.21.23
PRESS STATEMENT: FOR IMMEDIATE RELEASE June 20, 2023 National Ryan White Clinic Organization Fires Back at Gilead-Funded “Study” Riddled with Inaccuracies, Faulty Assumptions, and Profit-Centered Analysis The…
Novo Nordisk Tightens Restrictions on 340B Drugs Dispensed by Contract Pharmacies; Organon Becomes the 22nd Manufacturer to Issue Restrictions On June 1, 2023, Novo Nordisk and Organon each announced restrictions…
Gilead Funds BRG Study Taking Aim at 340B Grantees On May 22, 2023, the Berkeley Research Group (BRG) published a “study” titled “Federal Grantee Clinics and the 340B Drug…
Pharmaceutical Manufacturer 340B Price Restriction Policies and Exemptions Summary